123 related articles for article (PubMed ID: 31478530)
1. Desensitization to Filgrastim in a 2-Year-Old Girl With a Vaginal Endodermal Sinus Tumor.
González-Cavero L; Gómez-Traseira C; Fiandor A; Entrala A; Quirce S
J Investig Allergol Clin Immunol; 2019 Aug; 29(4):329-330. PubMed ID: 31478530
[No Abstract] [Full Text] [Related]
2. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
Ludwig H; Bokemeyer C; Aapro M; Boccadoro M; Gascón P; Denhaerynck K; Krendyukov A; Abraham I; MacDonald K
Future Oncol; 2019 Mar; 15(8):897-907. PubMed ID: 30827127
[TBL] [Abstract][Full Text] [Related]
3. [A new case of vaginal endodermal sinus tumor in an infant].
Grumbach Y; Piussan C; Remond A; Audebert M; Minh HN; Reguet C
Ann Pediatr (Paris); 1976 Mar; 23(3):207-11. PubMed ID: 16104229
[No Abstract] [Full Text] [Related]
4. Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study.
Nahon S; Rastkhah M; Ben Abdelghani M; Soumoudronga RF; Gasnereau I; Labourey JL
Support Care Cancer; 2016 May; 24(5):1991-1998. PubMed ID: 26507190
[TBL] [Abstract][Full Text] [Related]
5. Endodermal sinus tumor of the vagina in children.
Lopes LF; Chazan R; Sredni ST; de Camargo B
Med Pediatr Oncol; 1999 May; 32(5):377-81. PubMed ID: 10219341
[No Abstract] [Full Text] [Related]
6. A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Ibrahim MFK; Hilton J; Mazzarello S; Fergusson D; Hutton B; Robinson A; Califaretti N; Hsu T; Gertler S; Mates M; Stober C; Vandermeer L; Mallick R; Clemons M
Breast Cancer Res Treat; 2018 Apr; 168(2):371-379. PubMed ID: 29214415
[TBL] [Abstract][Full Text] [Related]
7. Endodermal sinus tumor of vagina posing a diagnostic challenge and managed by chemotherapy and novel posterior sagittal surgical approach: lessons learned.
Goyal S; Puri A; Mishra K; Aggarwal SK; Kumar M; Sonaker P
J Obstet Gynaecol Res; 2014 Feb; 40(2):632-6. PubMed ID: 24118204
[TBL] [Abstract][Full Text] [Related]
8. Vaginal yolk sac tumor in a nine-month-old female child.
Catipović M; Crnojević-Ivanusić R; Dujsin M; Batinica S; Cacić M; Markoja I
Croat Med J; 1998 Mar; 39(1):66-8. PubMed ID: 9475811
[TBL] [Abstract][Full Text] [Related]
9. Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study.
Weycker D; Doroff R; Hanau A; Bowers C; Belani R; Chandler D; Lonshteyn A; Bensink M; Lyman GH
BMC Cancer; 2019 Aug; 19(1):792. PubMed ID: 31399079
[TBL] [Abstract][Full Text] [Related]
10. First Pegfilgrastim Biosimilar Approved.
Aschenbrenner DS
Am J Nurs; 2018 Oct; 118(10):19-20. PubMed ID: 30260881
[No Abstract] [Full Text] [Related]
11. Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study).
Aapro M; Bokemeyer C; Ludwig H; Gascón P; Boccadoro M; Denhaerynck K; Gorray M; Krendyukov A; MacDonald K; Abraham I
J Geriatr Oncol; 2017 Mar; 8(2):86-95. PubMed ID: 27829539
[TBL] [Abstract][Full Text] [Related]
12. Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.
Pettengell R; Bias P; Mueller U; Lang N
Support Care Cancer; 2016 Jun; 24(6):2677-84. PubMed ID: 26780505
[TBL] [Abstract][Full Text] [Related]
13. Compatibility of Biosimilar Filgrastim with Cytotoxic Chemotherapy during the Treatment of Malignant Diseases (VENICE): A Prospective, Multicenter, Non-Interventional, Longitudinal Study.
Fruehauf S; Otremba B; Stötzer O; Rudolph C
Adv Ther; 2016 Nov; 33(11):1983-2000. PubMed ID: 27743353
[TBL] [Abstract][Full Text] [Related]
14. Endodermal sinus tumor in children.
Davidoff AM; Hebra A; Bunin N; Shochat SJ; Schnaufer L
J Pediatr Surg; 1996 Aug; 31(8):1075-8; discussion 1078-9. PubMed ID: 8863237
[TBL] [Abstract][Full Text] [Related]
15. Yolk sac tumor of vagina: a rare cause of vaginal bleeding in adolescents - a case report.
Elbaz M; Qadiry RE; Fouraiji K; Jalal H; Elhoudzi J
Pan Afr Med J; 2020; 37():169. PubMed ID: 33425202
[TBL] [Abstract][Full Text] [Related]
16. Endodermal sinus tumor of the vagina.
Bochner BH; De Filippo RE; Hardy BE
J Urol; 2000 Apr; 163(4):1293. PubMed ID: 10737532
[No Abstract] [Full Text] [Related]
17. Painful subcutaneous nodules on the trunk and forearm in a young man.
Wang CH; Kuo TT; Chen CB
Indian J Dermatol Venereol Leprol; 2021; 87(6):833-836. PubMed ID: 31898638
[No Abstract] [Full Text] [Related]
18. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
Smith TJ; Bohlke K; Lyman GH; Carson KR; Crawford J; Cross SJ; Goldberg JM; Khatcheressian JL; Leighl NB; Perkins CL; Somlo G; Wade JL; Wozniak AJ; Armitage JO;
J Clin Oncol; 2015 Oct; 33(28):3199-212. PubMed ID: 26169616
[TBL] [Abstract][Full Text] [Related]
19. A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
Park KH; Lee S; Park JH; Kang SY; Kim HY; Park IH; Park YH; Im YH; Lee HJ; Park S; Lee SI; Jung KH; Kim YS; Seo JH
Support Care Cancer; 2017 Feb; 25(2):505-511. PubMed ID: 27709313
[TBL] [Abstract][Full Text] [Related]
20. New perspectives on therapy for vaginal endodermal sinus tumors.
Handel LN; Scott SM; Giller RH; Greffe BS; Lovell MA; Koyle MA
J Urol; 2002 Aug; 168(2):687-90. PubMed ID: 12131350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
